Preview

Cardiovascular Therapy and Prevention

Advanced search

Endovascular myocardial revascularization in patients with multivessel coronary artery disease with chronic total occlusion and high surgical risk

https://doi.org/10.15829/1728-8800-2020-2697

Abstract

The main reason  for incomplete myocardial revascularization is the presence of chronic coronary total occlusion (CTO), which is detected in every fourth patient during coronary angiography. At the same time, a generally accepted approach  to the treatment of CTO has not yet been developed.

Aim. To assess the rationale of complete myocardial revascularization in patients with multivessel coronary artery disease  (CAD) with chronic total occlusion and high surgical risk.

Material and methods. This retrospective,  open-label,  non-randomized clinical trial was carried out included 180 patients multivessel CAD and CTO. The patients  underwent endovascular  surgery for complete myocardial revascularization. Depending on the success of surgery, the patients were divided into groups of complete and incomplete myocardial revascularization. Endpoints were death, acute coronary syndrome, re-revascularization after 1-year follow-up. Left ventricular (LV) contractility and clinical status  of patients  in the study groups after 1 year of observation was assessed.

Results. The median follow-up was 12,1 months. The successful  rate of revascularization was 79,4%. The incidence of main composite endpoint in the group of complete myocardial revascularization was 5,59%, while in the group of incomplete revascularizations — 21,6% (p=0,005).

Conclusion. The study showed  that low incidence  of intraoperative complications and a high successful  rate of revascularization are characteristic of complete myocardial revascularization in patients at high surgical risk with multivessel CAD and CTO. Complete myocardial revascularization leads to a significant decrease in the incidence of major coronary events.

About the Authors

D. K. Vasiliev
National Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


B. A. Rudenko
National Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


A. S. Shanoyan
National Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


F. B. Shukurov
National Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


D. A. Feshchenko
National Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


References

1. Fefer P, Knudtson M, Cheema A, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J AmCollCardiol 2012;59:991-7. doi: 10.1016/j.jacc.2011.12.007

2. Ramunddal T, at al. Chronic total occlusions in Sweden--a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).PLoS One. 2014 Aug 12;9(8):e103850. doi: 10.1371/journal.pone.0103850.

3. Werner GS, et al. Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice.Clin Res Cardiol. 2009 Jul;98(7):435-41. doi: 10.1007/s00392-009-0013-5.

4. Tomasello SD, Boukhris M, Giubilato S, et al. 
Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. EurHeart J 2015;36:3189-98.doi: 10.1093/eurheartj/ehv450

5. Sapontis J, Salisbury A, Yeh R, et al. Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty: A Report From the OPEN-CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures). JACC CardiovascInterv 2017;10:1523-34.doi: 10.1016/j.jcin.2017.05.065

6. Habara M, Tsuchikane E, Muramatsu T, et al. Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience
from the Japanese retrograde summit registry. CatheterCardiovascInterv 2016;87:1027-35. doi: 10.1002/ccd.26354

7. Werner GS, Martin-Yuste V, Hildick-Smith D,
et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. EurHeart J 2018;39:2484-93.doi: 10.1093/eurheartj/ehy220.

8. Lee SW, Lee PH, et al. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion. Circulation. 2019 Apr 2;139(14):1674-1683. doi: 10.1161/CIRCULATIONAHA.118.031313.

9. Elias J, van Dongen IM, Råmunddal T, et al. Longterm impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction. Heart 2018;104:1432-8.doi: 10.1136/heartjnl-2017-312698. Epub 2018 Feb 20.

10. Sianos G, Werner G, Galassi A, et al. Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club. EuroIntervention 2012;8:139-45. doi: 10.4244/EIJV8I1A21.

11. Patrick W. Serruys, M.D., Ph.D., Marie-Claude Morice, M.D., A. Pieter Kappetein, M.D., Ph.D., Antonio Colombo, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med 2009; 360:961-972. doi: 10.1056/NEJMoa0804626.

12. Jang WJ, Yang JH, Choi SH, et al. Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well- developed collateral circulation. JACC CardiovascInterv 2015;8:271-9.doi: 10.1016/j.jcin.2014.10.010. 


13. George S, Cockburn J, Clayton TC, et al. Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database. J AmCollCardiol 2014;64:235-43. doi: 10.1016/j.jacc.2014.04.040.

14. Ma Y, Li D, Li J, Li Y, Bai F, Qin F, Zhou S, Liu Q. Percutaneous coronary intervention versus optimal medical therapy for patients with chronic total occlusion: a meta-analysis and systematic review. J Thorac Dis. 2018 May;10(5):2960-2967. doi: 10.21037/jtd.2018.04.140.

15. Abo-Aly M, et al. Percutaneous Coronary Intervention With Drug-Eluting Stent Versus Optimal Medical Therapy for Chronic Total Occlusion: Systematic Review and Meta-Analysis.Angiology. 2019 Nov;70(10):908-915. doi:10.1177/0003319719858823.

16. Boukantar M, Loyeau A, et al. Angiography and Percutaneous Coronary Intervention for Chronic Total Coronary Occlusion in Daily Practice (from a Large French Registry [CARDIO-ARSIF]).Am J Cardiol. 2019 Sep 1;124(5):688-695. doi: 10.1016/j.amjcard.2019.05.062.

17. Kai-Ze Wu, et al. Successful treatment of complex coronary chronic total occlusions improves midterm outcomes. Ann Transl Med 2019;7(9):194doi: 10.21037/atm.2019.05.09.

18. Hannan EL, Racz M, Holmes DR, et al. Impact of completeness of percutaneouscoronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006;113:2406-2412.

19. Head SJ, Mack MJ, Holmes DR Jr, et al. Incidence, predictors andoutcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: A subgroupanalysis of 3-year SYNTAX data. Eur J Cardiothorac Surg. 2012;41:535-541.

20. Quadri G, D'Ascenzo F, Moretti C, et al. Gaita complete or incompletecoronary revascularisation in patients with myocardial infarction andmultivessel disease: A propensity score analysis from the "real-life"BleeMACS (bleeding complications in a multicenter registry of patientsdischarged with diagnosis of acute coronary syndrome) registry. Euro-Intervention. 2017;13:407-414.

21. Seung-Whan Lee , Pil Hyung Lee, Jung-Min Ahn, et al. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion. The DECISION-CTO Trial. doi:10.1161/CIRCULATIONAHA.118.031313


Supplementary files

Review

For citations:


Vasiliev D.K., Rudenko B.A., Shanoyan A.S., Shukurov F.B., Feshchenko D.A. Endovascular myocardial revascularization in patients with multivessel coronary artery disease with chronic total occlusion and high surgical risk. Cardiovascular Therapy and Prevention. 2020;19(6):2697. (In Russ.) https://doi.org/10.15829/1728-8800-2020-2697

Views: 1851


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)